NRX Pharmaceuticals, Inc.
NRXPNasdaqCIK 1719406HealthcareFiscal year ends Dec 31
Reports and events: 211 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1621:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-032828 |
| 2026-10-0521:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-032042 |
| 2026-09-1601:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-030492 |
| 2026-09-1412:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-030228 |
| 2026-08-1712:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-028111 |
| 2026-08-1420:32 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-028027 |
| 2026-08-0711:00 ET | 8-K | 7.01 Regulation FD disclosure | 0001437749-26-026428 |
| 2026-07-2211:00 ET | 8-K | 8.01 Other events | 0001437749-26-024037 |
| 2026-06-0421:20 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-019576 |
| 2026-06-0221:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-019196 |
| 2026-05-1520:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-017397 |
| 2026-03-2420:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-009611 |
| 2026-03-2320:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-009418 |
| 2026-02-2322:00 ET | DEF 14A | Proxy statementPeriod 2026-03-23 | 0001437749-26-005119 |
| 2026-02-1714:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-004246 |
| 2026-02-1714:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-004245 |
| 2026-02-0222:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-26-002682 |
| 2026-01-1622:09 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-001455 |
| 2025-12-2921:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-038835 |
| 2025-11-2621:31 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001437749-25-036452 |
| 2025-11-2121:32 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001437749-25-036005 |
| 2025-11-1421:32 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-035210 |
| 2025-10-2320:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-031637 |
| 2025-09-2612:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-029907 |
| 2025-09-1220:33 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-028949 |
| 2025-09-0820:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-028567 |
| 2025-08-1820:31 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-027256 |
| 2025-08-1810:07 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-027167 |
| 2025-08-1501:47 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-027059 |
| 2025-06-0916:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-019803 |
| 2025-05-2120:38 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-018000 |
| 2025-05-1521:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-017252 |
| 2025-05-1312:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-016272 |
| 2025-04-3020:33 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001437749-25-013874 |
| 2025-04-1721:24 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-012303 |
| 2025-03-2121:21 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-008777 |
| 2025-03-1420:31 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-007743 |
| 2025-02-0321:40 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-002610 |
| 2025-01-2922:10 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-002160 |
| 2025-01-2221:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-001569 |
| 2025-01-1421:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001437749-25-001113 |
| 2025-01-1013:32 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-000801 |
| 2024-11-2014:00 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-24-035806 |
| 2024-11-1522:24 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-035521 |
| 2024-11-1421:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-035289 |
| 2024-11-1417:21 ET | S-1 | Registration statement | 0001437749-24-035167 |
| 2024-10-3112:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-032705 |
| 2024-10-1520:52 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-24-031268 |
| 2024-10-1120:53 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-031133 |
| 2024-09-0520:18 ET | DEF 14A | Proxy statementPeriod 2024-10-08 | 0001437749-24-028549 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.